Neurofeedback, following protocols outlined and used by the neuroCare Group, is an effective method of treating ADHD and sleep disorders. neuroCare Group actively partners with several research institutions worldwide, to better understand the effects of neurofeedback in the ADHD population (both in children and adults). See below for further details and quality assurance of the neuroCare approach to delivering evidence-based neurofeedback protocols.
Garcia-Pimenta et al. 2021
Treatment Efficacy and Clinical Effectiveness of EEG Neurofeedback as a Personalized and Multimodal Treatment in ADHD: A Critical Review
The study confirms the effectiveness of Neurofeedback when personalised with a Quantitative EEG assessment, but also demonstrates that results improve when this method is used in combination with parental interventions, psychotherapy, sleep hygiene maintenance as well as nutritional advice.
Sustained effects of neurofeedback in ADHD: a systematic review and meta-analysis
This is a systematic review and meta-analysis which looks at data from more than 500 children with ADHD from 10 randomised controlled trials, comparing the effects of Neurofeedback with ‘active treatments’ (including medication and ‘non-active’ (no treatment) conditions. To critically interpret the data, researchers with different views on Neurofeedback contributed to this study. They concluded that Neurofeedback had long-lasting effects after an average of 6 months, with no ongoing therapy sessions needed after the initial program compared to the group which was still taking medication at follow-up, and at follow-up, the effects of neurofeedback were comparable to the effects of medication.
Strehl et al. 2017
Neurofeedback of Slow Cortical Potentials in Children with ADHD: A Multicenter Randomized Trial Controlling for Unspecific Effects
This is the largest multi-centre randomised study on SCP Neurofeedback, in 150 children with ADHD. The study confirms the specific efficacy of SCP neurofeedback on the core symptoms of ADHD compared to a semi-active control group. This demonstrates the feasibility and, above all, the efficacy of SCP neurofeedback in children with ADHD, controlling for specific and unspecific effects.
Krepel et al. 2020
A multicenter effectiveness trial of QEEG-informed neurofeedback in ADHD: Replication and treatment prediction
Arns et al. 2012
The Effects o QEEG-Informed Neurofeedback in ADHD: An Open-Label Pilot Study
This paper demonstrates the results of the ‘individualized’ neurofeedback approach – also called QEEG informed neurofeedback – which is employed within neuroCare Clinics worldwide. This manuscript also summarises how personalisation of neurofeedback treatment, both within this study and in an earlier study by an independent group, potentially doubles clinical treatment effects.
Ryan et al. 2019
What’s Sleep Got To Do with it? Circadian Rhythm Sleep Disorder, ADHD and Neurofeedback
Dr Ryan exlores the role of sleep in ADHD to explain the positive effects of Neurofedback as a treatment option in this patient group.
neuroCare Clinics Australia
Experienced providers of Neurofeedback now in Australia. Clinics across Sydney and Melbourne.
Would you like to find out more about our Neurofeedback programs?
Submit your enquiry today and one of our experienced staff will be in touch to explain the next steps.
neuroCare is innovating mental health and performance by personalising therapy following a detailed assessment. neuroCare’s objective, measurable and effective approach is based on our natural ability to learn (neuroplasticity) and technology to accelerate the learning (neuromodulation).